Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Baxter
McKinsey
Merck
Express Scripts

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

Sodium nitrite - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for sodium nitrite and what is the scope of freedom to operate?

Sodium nitrite is the generic ingredient in two branded drugs marketed by Hope Pharms and is included in two NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sodium nitrite has fifteen patent family members in eleven countries.

There are one thousand four hundred and seventy-two drug master file entries for sodium nitrite. One supplier is listed for this compound.

Summary for sodium nitrite
Recent Clinical Trials for sodium nitrite

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institutes of Health (NIH)Phase 1
Gladwin, Mark, MDPhase 1
National Heart, Lung, and Blood Institute (NHLBI)Phase 2/Phase 3

See all sodium nitrite clinical trials

Medical Subject Heading (MeSH) Categories for sodium nitrite
Synonyms for sodium nitrite
32863-15-3
56227-20-4
7632-00-0
82497-43-6
82998-40-1
AC1Q1VAY
AC1Q4THG
AKOS024427981
Anti-rust
ANW-36776
Azotyn sodowy
Azotyn sodowy [Polish]
CAS-7632-00-0
Caswell No. 782
CCRIS 559
CHEBI:78870
CHEMBL93268
CTK2H7764
D05865
DB09112
diazoting salts
Diazotizing salts
DSSTox_CID_941
DSSTox_GSID_20941
DSSTox_RID_75879
DTXSID0020941
Dusitan sodny [Czech]
E250
EC 231-555-9
EINECS 231-555-9
EPA Pesticide Chemical Code 076204
Erinitrit
Filmerine
FT-0645124
HMS3652K08
HSDB 757
I14-90844
KB-60553
KS-00000WUJ
KSC377O6J
LPXPTNMVRIOKMN-UHFFFAOYSA-M
M0KG633D4F
MFCD00011118
MolPort-003-926-309
NaNO2
Natrium nitrit
Natrium nitrit [German]
natrium nitrite
NCGC00090737-01
NCGC00090737-02
NCGC00254137-01
NCGC00259704-01
NCI-C02084
Nitrite de sodium
Nitrite de sodium [French]
Nitrite ion standard solution, 0.01 M NO2-, for ion-selective electrodes
Nitrite ion standard solution, 0.1 M NO2-, for ion-selective electrodes
Nitrite, sodium
Nitrito sodico
Nitrito sodico [Spanish]
Nitrous acid, sodium salt
Nitrous acid, sodium salt (1:1)
NNaO2
NSC 77391
RP18285
RTR-037707
S0565
s209
s4074
SC-46815
sodium nitrit
Sodium nitrite (TN)
Sodium nitrite (USP)
Sodium nitrite [UN1500] [Oxidizer]
Sodium nitrite [UN1500] [Oxidizer]
Sodium Nitrite [USAN]
Sodium nitrite [USP]
Sodium nitrite ACS grade
Sodium nitrite solution
Sodium nitrite solution, 40 wt. % in H2O
Sodium nitrite, >=99.99% trace metals basis
Sodium nitrite, 97+%, ACS reagent
Sodium nitrite, 98.5%, for analysis
Sodium nitrite, 99.5%, super free-flowing
Sodium nitrite, 99.999% trace metals basis
Sodium nitrite, 99%, extra pure, contains an anticaking reagent
Sodium nitrite, ACS reagent, >=97.0%
Sodium nitrite, analytical standard
Sodium nitrite, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=97%
Sodium nitrite, AR, >=98%
Sodium nitrite, granular, 99.5%
Sodium nitrite, JIS special grade, >=98.5%
Sodium nitrite, LR, >=98%
Sodium nitrite, p.a., ACS reagent, 99%
Sodium nitrite, puriss. p.a., ACS reagent, >=99.0% (RT)
Sodium nitrite, puriss. p.a., ACS reagent, reag. Ph. Eur., >=99%
Sodium nitrite, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E 250, 99-100.5% (calc. to the dried substance)
Sodium nitrite, purum p.a., >=98.0% (RT)
Sodium nitrite, ReagentPlus(R), >=99.0%
Sodium nitrite, SAJ first grade, >=97.0%
Sodium nitrite, Trace metals grade
Sodium nitrite, United States Pharmacopeia (USP) Reference Standard
Sodium nitrite,food grade
sodium-nitrite
sodiumnitrite
SW219150-1
Synfat 1004
Tox21_202155
Tox21_300025
TR-037707
TRA0042859
UN1500
UNII-M0KG633D4F

US Patents and Regulatory Information for sodium nitrite

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hope Pharms SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922-001 Feb 14, 2012 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444-001 Jan 14, 2011 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444-001 Jan 14, 2011 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444-001 Jan 14, 2011 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444-001 Jan 14, 2011 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for sodium nitrite

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0480717 98C0022 France   Start Trial PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
1912999 2014/058 Ireland   Start Trial PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516
0806968 SPC/GB07/011 United Kingdom   Start Trial PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003
2203431 1590018-6 Sweden   Start Trial PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
0268956 1999C0030 Belgium   Start Trial PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508
1948158 1690020-1 Sweden   Start Trial PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123
0957929 06C0021 France   Start Trial PRODUCT NAME: PEGAPTANIB SODIUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Merck
Boehringer Ingelheim
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.